UK: Commercial Framework Sheds Light On Working With NHS And NICE
Executive Summary
The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.
You may also be interested in...
Fair Pricing A Key Feature Of NHS England Drug Funding Proposals
Plans for a new commercial framework for publicly funded medicines in England are out for consultation. The concept of fair and responsible pricing figures large in the proposals.
Regulators Call for More Harmonization On Ultra-Rare ATMPs
Early discussions between companies and multiple regulators could drive greater alignment among jurisdictions.
Can The UK Remain A First Launch Market?
More pollical support from the National Health Service and health ministers is needed to ensure the UK’s future as a desirable launch market.